Table 1.
Clinical features of patients in the study
| APS group | SN-APS group | |
|---|---|---|
| Number in study | 40 | 40 |
| Gender | ||
| Male | 4 | 0 |
| Female | 36 | 40 |
| Mean age at sample | 45.3 | 46.1 |
| Diagnosis | ||
| PAPS | 22 | N/A |
| SLE/APS | 18 | N/A |
| SN-PAPS | N/A | 35 |
| SN-APS/SLE | N/A | 5 |
| Thrombosis | 34 | 25 |
| Venous | 19 | 12 |
| Arterial | 15 | 13 |
| None | 6 | 15 |
| Pregnancies? | ||
| Yes | 33 | 39 |
| No | 3 | 1 |
| N/A | 4 | 0 |
| Pregnancy morbidity | 23 | 35 |
| Miscarriage | 12 | 29 |
| Stillbirth | 19 | 25 |
| Prematurity | 4 | 7 |
| Preeclampsia | 7 | 10 |
| None | 17 | 5 |
| LA positivity | ||
| Yes | 27 | 0 |
| No | 13 | 40 |
LA, lupus anticoagulant; PAPS, Primary Antiphospholipid Syndrome; SLE, systemic lupus erythematosus; SN-APS, seronegative antiphospholipid syndrome.